Press Releases
Philogen’s management team will hold a webinar on 29 September 2022 at 16:00 CEST
Philogen’s management team will hold a webinar on 29 September 2022 at 10:00 ET / 15:00 BST / 16:00 CEST following an R&D Update. Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi,...
Read morePhilogen announces publication of IL12-7NP2 (an Interleukin-12 fusion protein against Fibroblast Activation Protein) in Journal for Immunotherapy of Cancer.
The study shows selective tumor uptake of IL12-7NP2 and potent antitumor activity as single agent and in combination with immune checkpoint inhibitors. The product is well tolerated when administered to...
Read moreUpcoming Events
Philogen to attend Emerging Technologies and Methodologies in Small Molecule Drug Discovery & Synthesis Symposium in Toledo (27-29 September 2022)
Philogen attends the Small Molecule Drug Discovery & Synthesis Symposium organized by Janssen in September 2022. Prof. Dario Neri, PhD, CEO and CSO of Philogen, to give a presentation entitled...
Read morePhilogen to attend the Festival of Biologics in Basel (2-4 November 2022)
Philogen attends the Festival of Biologics in Basel in November 2022. Roberto De Luca, PhD, Head of Antibody Therapeutics at Philogen, to give a presentation entitled “Tripokin: tumor targeted delivery...
Read morePhilogen to attend the 10th International Symposium on DNA-Encoded Chemical Libraries in Boston (3-4 November 2022)
Philogen attends the Symposium on DNA-Encoded Chemical Libraries in November 2022. Prof. Dario Neri, PhD, CEO and CSO of Philogen, to give a presentation entitled “Quantification of DEL selections and...
Read morePast Events
Philogen to attend the Peptide Therapeutic Forum 2022 on August 25-26, 2022
Philogen announces its attendance at the Peptide Therapeutic Forum 2022. Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Small Molecule Therapeutics as an alternative...
Read morePhilogen to attend the International Mass Spectrometry Congress 2022 in Maastricht (August 27th-September 2nd, 2022)
Dr. Ettore Gilardoni, Head of Bio-MS at Philogen, will present a poster entitled: A mass spectrometry-based method for the determination of in vivo biodistribution of small molecule-metal conjugates. Dr. Gilardoni...
Read morePhilogen to the 12th European Post-Chicago Melanoma/Skin Cancer Meeting, 30-1 July
Philogen will be Bronze Sponsor of the Post-Chicago Meeting in Münich (30-1 July). Philogen will chair a Satellite Symposium on Friday July 1, 11.30-12.00 am. Dr. Alfredo Covelli, Philogen’s CMO,...
Read more